Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNYNF) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to $15.2 billion.

  • Sanofi's Cost of Revenue rose 765.5% to $15.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $32.5 billion, marking a year-over-year increase of 3210.84%. This contributed to the annual value of $14.7 billion for FY2025, which is 317.95% up from last year.
  • According to the latest figures from Q4 2025, Sanofi's Cost of Revenue is $15.2 billion, which was up 765.5% from $10.9 billion recorded in Q3 2025.
  • In the past 5 years, Sanofi's Cost of Revenue registered a high of $15.2 billion during Q4 2025, and its lowest value of $3.0 billion during Q1 2025.
  • In the last 5 years, Sanofi's Cost of Revenue had a median value of $3.7 billion in 2021 and averaged $6.5 billion.
  • Its Cost of Revenue has fluctuated over the past 5 years, first soared by 127669.53% in 2021, then crashed by 930.62% in 2024.
  • Sanofi's Cost of Revenue (Quarter) stood at $14.0 billion in 2021, then fell by 0.34% to $14.0 billion in 2022, then dropped by 2.76% to $13.6 billion in 2023, then rose by 3.86% to $14.1 billion in 2024, then grew by 7.66% to $15.2 billion in 2025.
  • Its Cost of Revenue was $15.2 billion in Q4 2025, compared to $10.9 billion in Q3 2025 and $3.4 billion in Q2 2025.